🇺🇸 FDA
Patent

US 8877215

Compounds with modifying activity enhanced under hypoxic conditions

granted A61KA61K31/435A61K49/0017

Quick answer

US patent 8877215 (Compounds with modifying activity enhanced under hypoxic conditions) held by The Board of Regents of the University of Texas System expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/435, A61K49/0017